QUOTE AND NEWS
FierceBiotech  May 8  Comment 
After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents. Li, a Chinese national who worked for...
FiercePharma  May 8  Comment 
Long slated for closure, a Sanofi ($SNY) plant in Missouri is starting to unwind. Layoffs begin June 1 with 112 jobs cut, with more cuts following every 6 months until final shutdown in August 2016. The plant, which once was one of Sanofi's key...
StreetInsider.com  May 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/ZIOPHARM+%28ZIOP%29+Taps+Former+Sanofi+%28SNY%29+Exec+Amello+as+CFO/7412042.html for the full story.
The Economic Times  May 3  Comment 
Aventis Pharma today said its net profit declined by 20.75 per cent to Rs 40.1 crore for the first quarter ended March 31, 2012, over the same period previous year.
StreetInsider.com  May 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sanofi%27s+%28SNY%29+Genzyme+Gets+EMA%2C+FDA+Approval+for+Second+Suite+at+Irish+Plant/7398097.html for the full story.
PR Newswire  May 2  Comment 
BRIDGEWATER, N.J., May 2, 2012 /PRNewswire/ -- Sanofi US announced today that the iBGStar® Blood Glucose Monitoring System, consisting of the iBGStar® blood glucose meter and iBGStar® Diabetes Manager App, is commercially available in the U.S.
PR Newswire  May 1  Comment 
SWIFTWATER, Pa., May 1, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today new Phase III data for its investigational quadrivalent influenza vaccine (QIV) in children 6 months through 8
Market Intelligence Center  May 1  Comment 
Sanofi-Aventis (NYSE: SNY) closed Monday's trading session at $38.18. In the past year, the stock has hit a 52-week low of $30.98 and 52-week high of $40.75. Sanofi Aventis (SNY) stock has been showing support around $37.87 and resistance in the...
FiercePharma  Apr 30  Comment 
Sanofi ($SNY) had a good first quarter with higher revenues and profits, but executives acknowledge that with Plavix weeks away from coming off patent, the next 12 months will be tough. The French company reported a net profit of €1.83 billion...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki